Drug industry is partly to blame for overdiagnosis of bipolar disorder, researchers claimBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39577.442650.DB (Published 15 May 2008) Cite this as: BMJ 2008;336:1092
- Michael Day
Marketing tactics by the drug industry are contributing to a huge overdiagnosis of bipolar disorder, researchers have said.
A team from Brown University in Rhode Island says it has evidence that fewer than half of patients who were given a diagnosis of the disorder actually had it (Journal of Clinical Psychiatry www.psychiatrist.com/abstracts/oap/ej07m03888.htm). Their finding contradicts previous claims that the illness was underdiagnosed.
Lead researcher Mark Zimmerman of Rhode Island Hospital and Brown University, said: “There might well be some cases where the condition goes undiagnosed.
“But the results from this study suggest that bipolar disorder is being overdiagnosed, and, given the serious …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial